从游离DNA中回收载体整合位点
本研究开发了LiBIS-seq技术,一种优化的PCR方法,可从多种组织死亡细胞释放入血的游离DNA中定量回收载体整合位点。该技术实现了对肝脏靶向基因治疗的纵向监测和造血干细胞基因治疗患者的克隆追踪,相比仅分析循环血细胞的常规方法,能更早检测到外周组织中异常扩增的载体标记克隆。
要点
- LiBIS-seq可从游离DNA中定量回收载体整合位点。
- 可用于肝脏靶向基因治疗的纵向监测。
- 比常规血细胞分析更早发现外周组织异常克隆。
核心结论
- LiBIS-seq通过分析游离DNA中的载体整合位点,提升了对基因治疗安全性和克隆动态的监测能力。
研究设计与样本
- 本研究为方法学开发,基于聚合酶链反应(PCR)技术优化建立LiBIS-seq,用于从游离DNA中定量回收载体整合位点。
主要发现
- LiBIS-seq实现了对肝脏靶向基因治疗的纵向监测。
- LiBIS-seq在造血干细胞基因治疗患者中实现了克隆追踪。
- 与仅基于循环血细胞的常规分析相比,LiBIS-seq能更早检测到外周组织中异常扩增的载体标记克隆。
临床怎么用
- 可用于基因治疗患者的无创性克隆监测,尤其有助于评估外周组织中工程化细胞的克隆组成和更新。
局限性
- 原文未明确报告LiBIS-seq的检测灵敏度、特异性及样本量等性能参数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gene therapy (GT) has rapidly attracted renewed interest as a treatment for otherwise incurable diseases, with several GT products already on the market and many more entering clinical testing for selected indications. Clonal tracking techniques based on vector integration enable monitoring of the fate of engineered cells in the blood of patients receiving GT and allow assessment of the safety and efficacy of these procedures. However, owing to the limited number of cells that can be tested and the impracticality of studying cells residing in peripheral organs without performing invasive biopsies, this approach provides only a partial snapshot of the clonal repertoire and dynamics of genetically modified cells and reduces the predictive power as a safety readout. In this study, we developed liquid biopsy integration site sequencing, or LiBIS-seq, a polymerase chain reaction technique optimized to quantitatively retrieve vector integration sites from cell-free DNA released into the bloodstream by dying cells residing in several tissues. This approach enabled longitudinal monitoring of in vivo liver-directed GT and clonal tracking in patients receiving hematopoietic stem cell GT, improving our understanding of the clonal composition and turnover of genetically modified cells in solid tissues and, in contrast to conventional analyses based only on circulating blood cells, enabling earlier detection of vector-marked clones that are aberrantly expanding in peripheral tissues.
引用
- Cesana D, Calabria A, Rudilosso L, et al. Retrieval of vector integration sites from cell-free DNA. Nat Med. 2021. PMID: 34140705. doi:10.1038/s41591-021-01389-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。